The discovery of leptin in 1994 has led to remarkable advances in obesity research. We now know that leptin is a cytokinelike hormone that is produced in adipose tissue and plays a pivotal role in regulation of energy balance and in a variety of additional processes via actions in the central nervous system. This symposium review covers current understandings of neuronal leptin receptor signaling and mechanisms of obesity-related leptin resistance in the central nervous system and provides recent insights into the regulation of peripheral glucose balance by central leptin action in rodents.
ColemanDL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 1978;14:141–148.
2.
ZhangY, ProencaR, MaffeiM, . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432.
3.
AhimaRS, PrabakaranD, MantzorosC, . Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250–252.
4.
ChenH, CharlatO, TartagliaLA, . Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996;84:491–495.
5.
PelleymounterMA, CullenMJ, BakerMB, . Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269:540–543.
6.
FriedmanJM, HalaasJL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–770.
7.
BjørbaekC, KahnBB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res. 2004;59:305–331.
8.
ScottMM, LacheyJL, SternsonSM, . Leptin targets in the mouse brain. J Comp Neurol. 2009;514:518–532.
9.
AhimaRS, SaperCB, FlierJS, . Leptin regulation of neuroendocrine systems. Front Neuroendocrinol. 2000;21:263–307.
10.
BarshGS, FarooqiIS, O'RahillyS. Genetics of body-weight regulation. Nature. 2000;404:644–651.
11.
FriedmanJM. Obesity in the new millennium. Nature. 2000;404:632–634.
12.
SchwartzMW, WoodsSC, Porte D Jr, et al. Central nervous system control of food intake. Nature. 2000;404:661–671.
13.
ElmquistJK, BjorbaekC, AhimaRS, . Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol. 1998;395:535–547.
14.
MercerJG, HoggardN, WilliamsLM, . Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol. 1996;8:733–735.
15.
SatohN, OgawaY, KatsuuraG, . The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett. 1997;224:149–152.
16.
CoppariR, IchinoseM, LeeCE, . The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab. 2005;1:63–72.
17.
MortonGJ, NiswenderKD, RhodesCJ, . Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats. Endocrinology. 2003;144:2016–2024.
18.
ConeRD. Anatomy and regulation of the central melanocortin system. Nat Neurosci. 2005;8:571–578.
19.
CowleyMA, SmartJL, RubinsteinM, . Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411:480–484.
20.
OllmannMM, WilsonBD, YangYK, . Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 1997;278:135–138.
21.
vanden Top M, LeeK, WhymentAD, . Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci. 2004;7:493–494.
22.
BalthasarN, CoppariR, McMinnJ, . Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron. 2004;42:983–991.
23.
vande Wall E, LeshanR, XuAW, . Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology. 2008;149:1773–1785.
24.
HuoL, GamberK, GreeleyS, . Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab. 2009;9:537–547.
25.
DhillonH, ZigmanJM, YeC, . Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron. 2006;49:191–203.
26.
SatohN, OgawaY, KatsuuraG, . Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes. 1999;48:1787–1793.
27.
LechanRM, FeketeC. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res. 2006;153:209–235.
28.
HollenbergAN. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor. Thyroid. 2008;18:131–139.
29.
DonatoJJr, SilvaRJ, SitaLV, . The ventral premammillary nucleus links fasting-induced changes in leptin levels and coordinated luteinizing hormone secretion. J Neurosci. 2009;29:5240–5250.
30.
FultonS, PissiosP, ManchonRP, . Leptin regulation of the mesoaccumbens dopamine pathway. Neuron. 2006;51:811–822.
HuoL, GrillHJ, BjorbaekC. Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus. Diabetes. 2006;55:567–573.
33.
GrillHJ, SchwartzMW, KaplanJM, . Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology. 2002;143:239–246.
34.
GrillHJ, HayesMR. The nucleus tractus solitarius: a portal for visceral afferent signal processing, energy status assessment and integration of their combined effects on food intake. Int J Obes (Lond). 2009;(suppl 1):S11–S15.
35.
TartagliaLA, DembskiM, WengX, . Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995;83:1263–1271.
36.
LeeGH, ProencaR, MontezJM, . Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996;379:632–635.
37.
BjørbaekC, UotaniS, daSilva B, . Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem. 1997;272:32686–32695.
38.
LeinningerGM, MyersMGJr. LRb signals act within a distributed network of leptin-responsive neurones to mediate leptin action. ActaPhysiol (Oxf). 2008;192:49–59.
39.
MunzbergH, HuoL, NillniEA, . Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology. 2003;144:2121–2131.
40.
KitamuraT, FengY, KitamuraYI, . Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med. 2006;12:534–540.
41.
BjorbaekC, ElmquistJK, FrantzJD, . Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell. 1998;1:619–625.
42.
BjørbaekC, El-HaschimiK, FrantzJD, . The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem. 1999;274:30059–30065.
43.
BjorbakC, LaveryHJ, BatesSH, . SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem. 2000;275:40649–40657.
44.
ZabolotnyJM, Bence-HanulecKK, Stricker-KrongradA, . PTP1B regulates leptin signal transduction in vivo. Dev Cell. 2002;2:489–495.
45.
LundIK, HansenJA, AndersenHS, . Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J Mol Endocrinol. 2005;34:339–351.
46.
BenceKK, DelibegovicM, XueB, . Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med. 2006;12:917–924.
47.
GongL, YaoF, HockmanK, . Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis. Endocrinology. 2008;149:3346–3354.
48.
MützeJ, RothJ, GerstbergerR, . Nuclear translocation of the transcription factor STAT5 in the rat brain after systemic leptin administration. Neurosci Lett. 2007;417:286–291.
49.
BanksAS, DavisSM, BatesSH, . Activation of downstream signals by the long form of the leptin receptor. J Biol Chem. 2000;275:14563–14572.
NiswenderKD, GallisB, BlevinsJE, . Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J Histochem Cytochem. 2003;51:275–283.
52.
PardiniAW, NguyenHT, FiglewiczDP, . Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Brain Res. 2006;1112:169–178.
53.
RahmouniK, HaynesWG, MorganDA, . Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci. 2003;23:5998–6004.
54.
XuAW, KaelinCB, TakedaK, . PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest. 2005;115:951–958.
BlouetC, OnoH, SchwartzGJ. Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. Cell Metab. 2008;8:459–467.
58.
KimMS, PakYK, JangPG, . Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci. 2006;9:901–906.
59.
MinokoshiY, HaqueMS, ShimazuT. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes. 1999;48:287–291.
60.
CarlingD. The role of the AMP-activated protein kinase in the regulation of energy homeostasis. Novartis Found Symp. 2007;286:72–81.
61.
HayesMR, SkibickaKP, BenceKK, . Dorsal hindbrain 5′-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance. Endocrinology. 2009;150:2175–2182.
62.
ClaretM, SmithMA, BatterhamRL, . AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest. 2007;117:2325–2336.
63.
BatesSH, StearnsWH, DundonTA, . STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature. 2003;421:856–859.
64.
BjörnholmM, MünzbergH, LeshanRL, . Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J Clin Invest. 2007;117:1354–1360.
65.
XuAW, Ste-MarieL, KaelinCB, . Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding. Endocrinology. 2007;148:72–80.
66.
MesarosA, KoralovSB, RotherE, . Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab. 2008;7:236–248.
67.
KievitP, HowardJK, BadmanMK, . Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab. 2006;4:123–132.
68.
MunzbergH, FlierJS, BjorbaekC. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology. 2004;145:4880–4889.
69.
EnrioriPJ, EvansAE, SinnayahP, . Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 2007;5:181–194.
70.
HillJW, WilliamsKW, YeC, . Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest. 2008;118:1796–1805.
71.
PlumL, Ma X, Hampel B, et al. Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J Clin Invest. 2006;116:1886–1901.
72.
BelgardtBF, HuschA, RotherE, . PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metab. 2008;7:291–301.
73.
FrederichRC, HamannA, AndersonS, . Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med. 1995;1:1311–1314.
74.
MaffeiM, HalaasJ, RavussinE, . Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155–1161.
75.
HilemanSM, TornøeJ, FlierJS, . Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby canine kidney cells. Endocrinology. 2000;141:1955–1961.
76.
BanksWA. The blood-brain barrier as a cause of obesity. Curr Pharm Des. 2008;14:1606–1614.
77.
BanksWA, FarrellCL. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am J Physiol Endocrinol Metab. 2003;285:E10–E15.
78.
LevinBE, Dunn-MeynellAA, BanksWA. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol. 2004;286:R143–R150.
79.
CusinI, ZakrzewskaKE, BossO, . Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes. 1998;47:1014–1019.
80.
HaqueMS, MinokoshiY, HamaiM, . Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes. 1999;48:1706–1712.
81.
KamoharaS, BurcelinR, HalaasJL, . Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389:374–377.
vanden Hoek AM, TeusinkB, VosholPJ, . Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. J Neuroendocrinol. 2008;20:120–127.
84.
OralEA, SimhaV, RuizE, . Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570–578.
85.
PetersenKF, OralEA, DufourS, . Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109:1345–1350.
86.
ShimomuraI, HammerRE, IkemotoS, . Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999;401:73–76.
87.
HuszarD, LynchCA, Fairchild-HuntressV, . Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131–141.
88.
FanW, DinulescuDM, ButlerAA, . The central melanocortin system can directly regulate serum insulin levels. Endocrinology. 2000;141:3072–3079.
